Turoctocog Alfa Pegol
展商:Novo Nordisk
原产国/地区:丹麦
Truncated B-domain-modified FVIII • GlycoPEGylation of turoctocog alfa’s truncated, 21-aa B-domain leads to an extended circulatory half-life1,2 • Activation of N8-GP yields native FVIIIa2-5 • Formulation and manufacturing without animal or human proteins2
展品详情
N8-GP (turoctocog alfa pegol)
Truncated B-domain-modified FVIII
• GlycoPEGylation of turoctocog alfa’s truncated, 21-aa B-domain leads to an extended circulatory half-life1,2
• Activation of N8-GP yields native FVIIIa2-5
• Formulation and manufacturing without animal or human proteins2
aa, amino acid; FVIIIa, activated factor VIII; PEG, polyethylene glycol
1. Thim L, et al. Haemophilia 2010;16:349–59;
2. Tiede A, et al. J Thromb Haemost 2013;11:670–8;
3. Giangrande P et al. Thromb Haemost 2017;117:252–61;
4. Agersø H et al. Haemophilia 2012;18:941–7;
5. Stennicke HR et al. Blood 2013;121:2108–16.